康拓医疗
(688314)
| 流通市值：7.88亿 | | | 总市值：17.46亿 |
| 流通股本：3668.78万 | | | 总股本：8123.92万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 308,934,158.47 | 375,119,786.33 | 235,047,417.46 | 194,453,926.4 |
| 应收票据及应收账款 | 5,459,007.91 | 9,317,376.3 | 8,888,248.39 | 7,387,684.16 |
| 应收账款 | 5,459,007.91 | 9,317,376.3 | 8,888,248.39 | 7,387,684.16 |
| 预付款项 | 7,642,078.6 | 4,945,719.6 | 4,802,318.5 | 5,127,060.23 |
| 其他应收款合计 | 1,019,461.33 | 920,491.66 | 1,464,287.93 | 1,207,754.78 |
| 存货 | 29,995,439.94 | 35,371,462.64 | 34,401,548.66 | 38,460,149.57 |
| 其他流动资产 | 986,282.47 | 975,903.8 | 958,243.45 | 810,711.29 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 439,036,428.72 | 426,650,740.33 | 410,562,064.39 | 383,447,286.43 |
| 非流动资产: | | | | |
| 长期股权投资 | 20,039,321.41 | 22,340,222.02 | 24,750,822.66 | 26,335,341.87 |
| 其他权益工具投资 | 3,752,700 | 3,002,700 | 3,002,700 | 3,002,700 |
| 投资性房地产 | 12,860,479.8 | 12,955,457.31 | 13,050,434.82 | 13,145,412.33 |
| 固定资产 | 123,403,798.38 | 123,980,427.71 | 125,380,124.55 | 126,809,221.34 |
| 在建工程 | 19,437,221.7 | 9,958,830.07 | 341,587.34 | 47,169.81 |
| 使用权资产 | 2,467,510.36 | 2,952,743.52 | 2,468,840.67 | 2,976,160.85 |
| 无形资产 | 20,417,545.76 | 21,199,331.57 | 22,152,340.64 | 23,039,238.14 |
| 长期待摊费用 | 4,962,668.91 | 6,346,623.7 | 6,568,900.76 | 7,354,480.85 |
| 递延所得税资产 | 3,223,209.2 | 3,294,741.71 | 3,004,702.06 | 3,081,672.1 |
| 其他非流动资产 | 45,266,782.35 | 43,105,585.18 | 42,275,334.86 | 40,470,199.44 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 255,831,237.87 | 249,136,662.79 | 242,995,788.36 | 246,261,596.73 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 694,867,666.59 | 675,787,403.12 | 653,557,852.75 | 629,708,883.16 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 16,778,712.23 | 16,844,707.96 | 11,267,121.05 | 9,912,024.06 |
| 应付账款 | 16,778,712.23 | 16,844,707.96 | 11,267,121.05 | 9,912,024.06 |
| 合同负债 | 3,075,461.64 | 1,941,122.17 | 2,203,678.52 | 3,395,131.43 |
| 应付职工薪酬 | 7,599,560.19 | 9,372,093.74 | 6,183,728.7 | 5,972,143.53 |
| 应交税费 | 9,172,710.14 | 8,436,212.15 | 9,158,578.03 | 9,138,298.35 |
| 其他应付款合计 | 5,395,825 | 4,891,074.77 | 4,914,305.66 | 5,390,489.27 |
| 一年内到期的非流动负债 | 38,098,677.64 | 37,971,140.05 | 37,920,227.41 | 38,045,198.44 |
| 其他流动负债 | 363,657.31 | 244,528.08 | 259,648.29 | 417,081.76 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 80,484,604.15 | 79,700,878.92 | 71,907,287.66 | 72,270,366.84 |
| 非流动负债: | | | | |
| 租赁负债 | 453,852.73 | 1,021,178.28 | 1,052,111.75 | 1,716,595.42 |
| 长期应付款 | 116,790.8 | 166,556.77 | 219,486.49 | 271,870.73 |
| 递延收益 | 5,850,605.5 | 5,965,695.07 | 2,569,742.98 | 2,324,524.23 |
| 递延所得税负债 | 3,193,280.42 | 3,422,744.81 | 3,549,063.8 | 3,805,149.6 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 9,614,529.45 | 10,576,174.93 | 7,390,405.02 | 8,118,139.98 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 90,099,133.6 | 90,277,053.85 | 79,297,692.68 | 80,388,506.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 81,239,172 | 81,239,172 | 81,239,172 | 81,239,172 |
| 资本公积 | 298,228,632.03 | 298,873,685.49 | 298,873,685.49 | 298,873,685.49 |
| 其他综合收益 | 1,948,991.13 | 2,348,076.47 | 3,622,820.56 | 3,767,831.63 |
| 盈余公积 | 39,824,264.91 | 39,824,264.91 | 28,676,464.26 | 28,676,464.26 |
| 未分配利润 | 184,833,987.97 | 164,898,864.5 | 164,192,549.07 | 139,026,040.52 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 606,075,048.04 | 587,184,063.37 | 576,604,691.38 | 551,583,193.9 |
| 少数股东权益 | -1,306,515.05 | -1,673,714.1 | -2,344,531.31 | -2,262,817.56 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 604,768,532.99 | 585,510,349.27 | 574,260,160.07 | 549,320,376.34 |
| 负债和股东权益合计 | 694,867,666.59 | 675,787,403.12 | 653,557,852.75 | 629,708,883.16 |
| 公告日期 | 2024-04-26 | 2024-04-13 | 2023-10-27 | 2023-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |